Results 111 to 120 of about 740 (167)

A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Int J Hematol
Yokota A, Munakata W, Kiguchi T, Ogawa Y, Hino M, Kato K, Chiba M, Kawasaki D, Wasa K, Mikasa T, Takeuchi K, Izutsu K, Suzuki R, Study Group.   +13 more
europepmc   +1 more source

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

J Clin Oncol
Pemmaraju N, Marconi G, Montesinos P, Lane AA, Mazzarella L, Sallman DA, Ulrickson ML, Schiller GJ, Erba HP, Wang ES, Walter RB, Deconinck E, Aribi A, Legrand O, Lebon D, Maisano V, Martinelli G, DeAngelo DJ, Derenzini E, Du Y, Lakshmikanthan S, Potluri J, Kantarjian HM, Daver NG.   +23 more
europepmc   +1 more source

Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Ann Hematol
Lee BJ.
europepmc   +1 more source

Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. [PDF]

Cancers (Basel)
Solana-Altabella A, Navarro-Vicente I, Rodríguez-Arbolí E, Noriega V, Serrano J, Bernal T, Carrasco-Baraja V, Garcia-Boyero R, Olivier Cornacchia C, Algarra L, López-Briz E, Mena-Durán A, Solano-Tovar J, Botella-Prieto C, Sánchez-Sánchez S, Bergua-Burgues JM, Lloret-Madrid P, Rodenas-Rovira M, Boluda B, Cano-Ferri I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Centelles-Oria M, Poveda-Andrés JL, Martínez-Cuadrón D, Montesinos P.   +26 more
europepmc   +1 more source

TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches. [PDF]

Front Oncol
Deshpande S, Li WF, Song J, Forsberg M, Cerchione C, Martinelli G, Konopleva M.   +6 more
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): international, multi-center collaboration and global registry program. [PDF]

Discov Oncol
Voskanyan A, Badikyan M, Konopleva M, Alencar A, Ivanyan A, Owen C, Sergi CM, Peng CT, Kazandjian D, Taylor J, Tekkesin F, Ghali H, Bedirian K, Martelli MP, Attardi E, Voso MT, Abramashvili M, Al-Jadiry MF, Michael M, Su MY, Martirosyan N, Ghahramanyan N, Totogashvili N, Kotoucek PP, Kebudi R, Ohannessian R, Papyan R, Hovsepyan S, Elashwah S, Bakhshi S, Bardakhchyan S, Danelyan S, El-Ashwah S, Kutluk T, Tuğcu D, Alhuraiji A, Lazaris V, Tamamyan G, Pemmaraju N.   +38 more
europepmc   +1 more source

Case Report: Blastic plasmacytoid dendritic cell neoplasm mimicking systemic lymphoma: a multidisciplinary diagnostic challenge. [PDF]

Front Med (Lausanne)
Lv B, Rong Q, Li Y, Zhang D.
europepmc   +1 more source

Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm

, 2019
Tandon, A., Zhang, Y., Sokol, L.
core   +1 more source

Delayed onset capillary leak syndrome with prolonged tagraxofusp use

JAAD Case Reports
Samuel Blount, Chase Pitchford, Joshua Brady, Jeffrey McBride, Jarad Levin   +4 more
openaire   +1 more source

Special Issue "Dendritic Cell and Cancer Therapy 2.0". [PDF]

Int J Mol Sci
Zanotta S, Galati D.
europepmc   +1 more source